Kalijn Bol
Kalijn Bol
Center for Cancer Immune Therapy Denmark and Radboudumc the Netherlands
Verified email at radboudumc.nl
Cited by
Cited by
Dendritic cell–based immunotherapy: state of the art and beyond
KF Bol, G Schreibelt, WR Gerritsen, IJM De Vries, CG Figdor
Clinical cancer research 22 (8), 1897-1906, 2016
Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
JFM Jacobs, AJ Idema, KF Bol, S Nierkens, OM Grauer, P Wesseling, ...
Neuro-oncology 11 (4), 394-402, 2009
Prognostic significance and mechanism of Treg infiltration in human brain tumors
JFM Jacobs, AJ Idema, KF Bol, JA Grotenhuis, IJM de Vries, P Wesseling, ...
Journal of neuroimmunology 225 (1-2), 195-199, 2010
Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination
EHJG Aarntzen, IJM De Vries, WJ Lesterhuis, D Schuurhuis, JFM Jacobs, ...
Cancer research 73 (1), 19-29, 2013
Effective clinical responses in metastatic melanoma patients after vaccination with primary myeloid dendritic cells
G Schreibelt, KF Bol, H Westdorp, F Wimmers, EHJG Aarntzen, ...
Clinical cancer research 22 (9), 2155-2166, 2016
Vaccination with mRNA-electroporated dendritic cells induces robust tumor antigen-specific CD4+ and CD8+ T cells responses in stage III and IV melanoma patients
EHJG Aarntzen, G Schreibelt, K Bol, WJ Lesterhuis, S Croockewit, ...
Clinical Cancer Research, clincanres. 3368.2012, 2012
Dendritic cell cancer therapy: vaccinating the right patient at the right time
WW Van Willigen, M Bloemendal, WR Gerritsen, G Schreibelt, ...
Frontiers in immunology 9, 2018
Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell based vaccination in metastatic melanoma
EHJG Aarntzen, K Bol, G Schreibelt, JFM Jacobs, WJ Lesterhuis, ...
Cancer research, canres. 2479.2012, 2012
Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination
KF Bol, EHJG Aarntzen, FEM Hout, G Schreibelt, JHA Creemers, ...
Oncoimmunology 5 (1), e1057673, 2016
Long overall survival after dendritic cell vaccination in metastatic uveal melanoma patients
KF Bol, HW Mensink, EHJG Aarntzen, G Schreibelt, JEE Keunen, ...
American journal of ophthalmology 158 (5), 939-947. e5, 2014
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
KF Bol, CG Figdor, EHJG Aarntzen, MEB Welzen, MM van Rossum, ...
Oncoimmunology 4 (8), e1019197, 2015
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
KF Bol, EHJG Aarntzen, JM Pots, MAMO Nordkamp, MWMM van de Rakt, ...
Cancer Immunology, Immunotherapy 65 (3), 327-339, 2016
Naturally circulating dendritic cells to vaccinate cancer patients
KF Bol, J Tel, IJM De Vries, CG Figdor
Oncoimmunology 2 (3), e23431, 2013
T-cell landscape in a primary melanoma predicts the survival of patients with metastatic disease after their treatment with dendritic cell vaccines
A Vasaturo, A Halilovic, KF Bol, DI Verweij, WAM Blokx, CJA Punt, ...
Cancer research, 2016
Adjuvant dendritic cell vaccination in high-risk uveal melanoma
KF Bol, T Van den Bosch, G Schreibelt, HW Mensink, JEE Keunen, E KiliÁ, ...
Ophthalmology 123 (10), 2265-2267, 2016
Immune-related adverse events of dendritic cell vaccination correlate with immunologic and clinical outcome in stage III and IV melanoma patients
S Boudewijns, H Westdorp, RHT Koornstra, EHJG Aarntzen, G Schreibelt, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 39 (6), 241, 2016
Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
S Boudewijns, KF Bol, G Schreibelt, H Westdorp, JC Textor, ...
Oncoimmunology 5 (7), e1191732, 2016
Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity
SV Hato, CG Figdor, S Takahashi, AE Pen, A Halilovic, KF Bol, A Vasaturo, ...
Oncotarget 8 (33), 54434, 2017
Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
S Boudewijns, RHT Koornstra, H Westdorp, G Schreibelt, ...
Oncoimmunology 5 (8), e1201625, 2016
Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
G Schreibelt, KF Bol, EHJG Aarntzen, WR Gerritsen, CJA Punt, CG Figdor, ...
Oncoimmunology 2 (6), e24440, 2013
The system can't perform the operation now. Try again later.
Articles 1–20